
MRgFUS trial reports Parkinson motor-complication gains
The prospective multicenter trial used Insightec’s Exablate Neuro system in 54 patients and reported a 66.8% motor-complication improvement after bilateral treatment.
Section
Imaging research, modality advances, and clinical practice updates.

The prospective multicenter trial used Insightec’s Exablate Neuro system in 54 patients and reported a 66.8% motor-complication improvement after bilateral treatment.

E-Scopics said its Hepatoscope-Derived Fat Fraction combines ultrasound attenuation and backscattering coefficient measurements to estimate intrahepatic fat at the point of care.

A Radiology study of 194 patients found sustained pain reduction and functional improvement after genicular artery embolization for osteoarthritis-related knee pain.

FDA approval covers gadoquatrane for detecting and visualizing lesions with abnormal vascularity in CNS and non-CNS body regions across adult and pediatric patients.

FDA clearance of the IND allows Pentixapharm to start the PANDA study of Ga-68 pentixafor for treatment-resistant hypertension with underlying primary aldosteronism.

The 25-patient oncology comparison found an 83% acquisition-time reduction and higher reader scores for image quality on a 128-cm long-axial field-of-view PET/CT system.

Mevion said the treatment was delivered inside an existing conventional radiation therapy vault using its S250-FIT system with Leo Cancer Care’s Marie platform.

An Auburn University graduate student underwent 104 MRI scans over 18 months while wearing a sleep-tracking ring to study next-day brain chemistry.

A Head & Neck case report from Vanderbilt described intraoperative PET/CT specimen imaging after resection in recurrent oral tongue squamous cell carcinoma.

The retrospective study of more than 110,000 women found lower breast cancer incidence among GLP-1 users, but researchers said the data do not prove causation.

International Urology and Nephrology review says rising renal cancer incidence with stable mortality may reflect increased incidental detection of small renal masses.

A Vanderbilt-led study of 5,757 Medicare beneficiaries found lower amyloid PET positivity odds among Black and Hispanic patients with cognitive impairment.

Archeus has started a phase I study pairing the Y-86 ARC-166 diagnostic agent with Y-90 ARC-706 therapy in metastatic cancer patients receiving immune checkpoint inhibitors.

A Nature Biotechnology study tested the abdomen-worn device against handheld ultrasound in 62 pregnancies and used continuous monitoring in 52 pregnant women.

Lurie Children’s reported early use of ultrasound-guided intercostal nerve cryoablation to reduce pain after rib-cartilage harvest for natural ear reconstruction.